Morgan “Caitlin” McKenna

Director, Office of Grant Support (OGS)

Phone: 718-430-3642 

Email: morgan.mckenna@einsteinmed.edu

Message from the Director


Hello,


In this April edition of the newsletter, I will provide details on our institutional submissions, office updates, sponsor updates, internal forms changes, system updates and proposal reminders.


Application Breakdown


Applications numbers have been analyzed for January 1 – April 30, 2025. OGS has already reviewed 382 applications (285 New, 16 Renewal, 73 Resubmission, 8 Supplement). The total cost request is $454,435,426. These applications were submitted by 53 Departments/Divisions across the institution. The funding breakdown: 43% Federal prime, 28% Federal and Non-Federal subcontracts, 23% Non-Federal prime, 4% Industry, and >1% New York State and 1% International.

Einstein leadership is reviewing the impact of executive orders and terminations of NIH grant awards. If you receive notice that your grant will be impacted or the parent award of a subcontract will be terminated, please contact Research Finance.


OGS Office Updates and Reminders


We are very excited to welcome a new member of our team in the role of Senior Grant Specialist, Michel Gauthier. He will join us 4/28. We are recruiting for a Grant Specialist. Come join our team!


Resource - Funding: OGS maintains an active license with SPINPlus portal. This portal has over 40,000 funding opportunities and allows investigators to set filters and receive notifications from the system of new field specific opportunities as they become available. Registration for May 6th is available at this link.


Reminder - Communication: Please ensure that communication and sponsor required clarifications route through OGS. As the Authorized Organization Representatives (AOR), we will review, provide feedback, and offer our concurrence for all direct sponsor communications.


Reminder – ProposalCentral: If you are submitting to a non-federal sponsor using ProposalCentral and you require institutional signature, you need to list the appropriate central office staff and provide edit access for the collection of signatures. All ProposalCentral full applications require an approved Cayuse record.


Reminder – Federal Applications: SF424 R&R page 1 “Person to be contacted on matters involving this application” list administrator information or Indranil Basu or Morgan McKenna. If you are submitting a DoD application list only OGS contact. SF424 R&R page 2 section for Authorized Representative please list Indranil Basu or Morgan McKenna. Applicant information should include Division as “Albert Einstein College of Medicine.”


Submission Policy Clarification (Enforcement): OGS requires the routing of proposals 8 business days prior to deadline for administrative documents. This includes the final budget, justification(s), Data Management and Sharing Plan (if applicable), biosketch of all key personnel, subcontract documents (signed SOI, performance site, biosketch of key persons, budget, and justification). If complete, you can also upload the Facilities and Other Resources, Equipment, Key Authentication, Vertebrate animal document and the Protection of Human Subjects and study record documents.


If you are collaborating with a foreign site(s), you are required to provide a signed letter of support for each site with the language listed on the supplemental form for OGS review.


We request the upload of final science 2 days prior to deadline (NIH recommendation).


Late Submission: Einstein leadership and OGS are developing a waiver form for late submissions. Process will require PI to obtain approval signature on waiver form from the Chair of the department or division chief requesting late review. If the chair is PI, they will need to have Deans office approval of late submission.


Reminder - Routing: All Cayuse applications require full routing and budget approval prior to submission to sponsors.


Reminder – New Sponsors: If you plan to work with a new sponsor, it is important that OGS review contract and/or award terms. Please route language to OGS prior to submission.


Reminder (Holiday or Office Closure): OGS will have coverage for urgent signatures and application deadline support. Please be proactive and route applications and signature requests to OGS in advance.


Federal Sponsor Updates and Resources


NIH Updates:



Funding Opportunities updated March 31st. Please read all funding opportunities very closely for changes in requirements and language. Changes have been made to align with administrative priorities.


NIH CAP – NOT-OD-25-085 Salary CAP increase has been confirmed 4/3/2025. Effective January 1, 2025, the salary cap for Executive Level II has been set at $225,700.


Common Forms - POSTPONED - Adoption for Biographical Sketch and Current and Pending (Other Support). All investigators will continue to use NIH-specific format pages until further notice. NSF is using SciENcv common forms (change live 5/20/2024).


Applications – Changes to requirements include the removal of Plans for Enhancing Diverse Perspectives (PEDP), Diversity Plans (R13, U13), Recruitment Plans to Enhance Diversity (T) no longer required, Training tables have been revised to remove calculations for % underrepresented minorities, Fellowships are using FORMS-H (for Parent opportunities) due to lack of update while non-parent opportunities will use FORMS-I package.


Note: If you submitted diversity-related components that were required at the time of deadline they will not be considered in the review.


New Award Condition – NOT-OD-090 The NIH requires certification that no funds will be used to support “programs that advance or promote DEI, DEIA, discriminatory equity ideology and any discriminatory prohibited boycott.”


NIH RePORTER Updates – We have submitted several requests to adjust public facing information on RePORTER. We have had mixed responses from the agencies of NIH. We suggest that you contact your PO prior to routing the requested change to OGS for further guidance and discussion of your proposed changes.


Peer Review – Simplified Review Framework for NIH Research Project Grant Applications (NOT-OD-24-010). This new framework and structure will begin with submission for due dates on or after January 25, 2025. Information concerning the framework is included in updated FONs. Resources for Simplified Review Framework webinar and overview of changes are available here.


Data Management and Sharing Plan (DMSP): OGS is not involved in the implementation of the DMSP. Please do not list OGS, RF, or any other central office on Element 6 of the plan, as this should be project personnel. OGS and Einstein IT are working on template language to share concerning institutional resources.


NIH Data Access and Security: Effective January 25, 2025, new and renewal users will be expected to secure data according to updated NIH Security Best Practices. Updated requirement for security of controlled-access data NOT-OD-24-157. 20 NIH Controlled access repositories (dbGAP, NDA, NIAGADS, etc.). Einstein IT will prepare plan to comply with regulation. Webinar: Community-Days-Securing-NIH-Controlled-Access-Genomic-Data.pptx


NIH – Clarification: NIH does not allow for overlapping or duplicative funding. Please read the extramural article on research integrity. Link: https://nexus.od.nih.gov/all/2024/10/04/the-how-and-why-of-recovery-of-grant-funds/


NIH Withdrawal: Avoid NIH administrative withdrawal of your application by communicating with the listed contact of the preferred agency in advance. This is recommended for all opportunities with limited agency involvement.


Upcoming Form and System updates: The required Cayuse Supplemental form is under review. This new form 5.1 will be circulated for use when the review is complete.


Reminder – Early Approval: Cayuse has added a required field to the proposal in SP (Early Approval /Submission Request). If you require an early review, select Yes, and enter the date in the text box. If you do not require an early review, select No. Please ensure your review request is consistent with the submission policy and provides reasonable turnaround time for OGS review. All documents should be complete and correct to ensure an early review can be completed on the requested date.


Training: Cayuse training will continue to be available monthly. Please contact OGS to request inclusion (OGS@einsteinmed.edu). OGS is creating training in specific areas including Other Support, Common Forms, and Budget Development.


Other support training was provided on February 11. The recording is available upon request. Additional training will be available in 2025.


Please continue to reach out to OGS for all your research administrative related inquiries. We look forward to continuing to provide a high level of support for your applications as well as clear updates on sponsor’s requirements and guidance to maximize funding success!


Sincerely,



M. Caitlin McKenna

OGS Workshop


How to find the grant opportunity via SPIN Plus Portal?

  

Mr. Bill DeCocco, Account Manager for InfoED Global, will be demonstrating live via Zoom how to use SPIN Plus Portal – one of the world’s largest databases of sponsored funding opportunities. Bill will cover all main aspects of SPIN Plus during the presentation and address any questions that may arise. Students, postdocs, residents, and faculty members are invited to attend. Please find the registration links below for the May - July training sessions.




Important links and documents

I) Einstein's institutional information, including UEI#, EIN#, New IPF#, Congressional District, Checks Should be Payable to, and more, can be accessed by clicking here. Please contact OGS in advance for detailed banking information regarding fund transfer.


II) The Einstein Pre-Award Forms (which include Cayuse Supplemental 5.0, eRA Commons account request, Cayuse user request, New Sponsor, PI certification, SOI lead and non-lead, and more) are available for download from this page.


III) Types of Letters for Grant Applications: Learn when and how to submit a reference lettercover letterletter of intentletter of support and other documents. Each key letter has a distinct purpose in informing peer reviewers, NIH staff, or both. Certain letters may be necessary while others are optional or should be left out, depending on your research plans and the type of your application. The subpages contain instructions on how to use each type of letter and what is required.



Delegate Authority to Someone

This topic discusses delegating authority directly to another user or to someone who needs to access your own account information. See Delegate on Behalf of Another User for delegating authority to a user on behalf of someone else. Not all roles can delegate all authorities; refer to the table in the Delegations topic for role-based constraints on delegation.

Read More

Understanding Grant Numbers

A grant number provides unique identification for the grant. This page provides a comprehensive explanation of all the components of a complete NIH grant number.

Read More

Deciphering NIH Application/Grant Numbers


The page contains a detailed list of application types and NIH funding institutes.


Link for NIH IC Acronyms

Updated eRA Commons User Guide


The updated eRA Commons user guide is available here.


Link for eRA Commons User Guide

Reference Letters

A reference letter and a letter of support are not the same. Referees are required to submit reference letters for certain programs, such as fellowships and career development awards. In order to be considered for the application, referees must submit these letters before the application deadline. Applications with less than the required number of reference letters will not be considered for review.

Read More

NIH Updates

NOT-OD-25-085: Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025

This notice provides information about the salary limitation for NIH grant and cooperative agreement awards, as well as extramural research and development contract awards. The salary levels of the Executive Pay Scale have been updated recently by the Office of Personnel Management. Effective January 1, 2025, the salary cap for Executive Level II has been set at $225,700.

Read More

NOT-OD-25-083: Implementation Update: Enhancing Security Measures for NIH Controlled-Access Data

In line with recent security directives, NIH is implementing a technical update to enhance security measures that are specifically designed to protect data provided by NIH Controlled-Access Data Repositories.

Read More

NOT-OD-25-090: Notice of Civil Rights Term and Condition of Award

This Notice alerts the extramural research community of a new Civil Rights term and condition that modifies the current terms and conditions for all NIH grants, cooperative agreements, and other transaction (OT) awards. This term applies prospectively to new, renewal, supplement, or continuation awards issued on or after the date of this Notice.

Read More

Implementation of New Initiatives and Policies

NIH grants and funding policies and processes are evolving as NIH aligns with new agency priorities. Keep on top of the latest status of changes impacting NIH grants administration and funding. NIH's adoption of the Common Form for Biographical Sketch and a new Biographical Sketch Supplement originally scheduled for May 25, 2025 is postponed.

Read More

Breast Cancer Research Program (BCRP)

The Breast Cancer Research Program (BCRP) released program announcements for the following funding opportunities:

·        Breakthrough Award Levels 1 and 2

·        Breakthrough Award Level 3

·        Clinical Research Extension Award

·        Era of Hope Scholar Award

To view the program announcements and submit a pre-application visit: 

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=663101

Read More

Ovarian Cancer Research Program (OCRP)

The Ovarian Cancer Research Program (OCRP) released program announcements for the following funding opportunities:

·        Investigator-Initiated Research Award

·        Ovarian Cancer Academy - Early-Career Investigator Award

·        Pilot Award

To view the program announcements and submit a pre-application visit: 

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=663103

Read More

Amyotrophic Lateral Sclerosis Research Program (ALSRP)

The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released program announcements for the following funding opportunities:

·        Pilot Clinical Trial Award 

·        Clinical Outcomes and Biomarkers Award

·        Therapeutic Development Award

·        Therapeutic Idea Award

To view the program announcements and submit a pre-application visit: 

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=663102

Read More

Alzheimer’s Research Program (AZRP)

The Alzheimer’s Research Program (AZRP) released program announcements for the following funding opportunities:

·        Transforming Care Award

·        Transforming Diagnosis Award

·        Transforming Research Award

To view the program announcements and submit a pre-application visit:  

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=663104

Read More

FY25 pre-announcements for Department of Defense (DOD) programs

A. The Melanoma Research Program (MRP) re-released a pre-announcement for the following anticipated funding opportunities:

·        Survivorship Research Award

·        Focused Program Award – Rare Melanomas

·        Melanoma Academy Leadership Award **Returning for FY25**

·        Idea Award

·        Melanoma Academy Scholar Award

·        Team Science Award

To view the MRP pre-announcement, visit https://cdmrp.health.mil/pubs/press/2025/25mrppreann

 

B. The Prostate Cancer Research Program (PCRP) released a pre-announcement for the following funding opportunities:

·        Clinical Consortium Award **Returning for FY25**

·        Idea Development Award

To view the pre-announcement, visit https://cdmrp.health.mil/pubs/press/2025/25pcrppreann

 

C. The Rare Cancers Research Program (RCRP) re-released a pre-announcement for the following funding opportunities:

·        Concept Award 

·        Idea Development Award

·        Resource and Community Development Award

To view the pre-announcement, visit https://cdmrp.health.mil/pubs/press/2025/25rcrppreann


D. The Peer Reviewed Cancer Research Program (PRCRP) released a pre-announcement for the following anticipated funding opportunities:

·        Career Development Award- Fellow and Resident Option

·        Career Development Award- Scholar Option

·        Idea Award

·        Impact Award- Partnering PI Option

·        Patient Well-Being and Survivorship Award

·        Clinical Trial Award

To view the pre-announcement, visit https://cdmrp.health.mil/pubs/press/2025/25prcrppreann

Read More

Non-Federal Funding Opportunities

Cancer research grants

Due: April 30, 2025

Amount: Flexible/1 year. Usually between $100k-$200k

The foundation funds innovative approaches to identifying new treatments or cures for cancer. Projects are for a one-year period to allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Grant amount requested must be reasonable and clearly supported by the scope of the project outlined in the application. The Foundation particularly welcomes innovative, small-scale, short-term projects which may be difficult to fund elsewhere until some

interesting results are obtained. Eligibility: Post-docs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers who are new to the field of cancer research, or to established research investigators examining new approaches to cancer.

Link: How to Apply

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

Emerging Leader Award | The Mark Foundation for Cancer Research

Due: May 5, 2025

Amount: $750,000 over three years


These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. This award is not intended to be the main source of funding for the applicant’s lab. Applicants must demonstrate multi-year independent funding that sustains the central activities of the lab.

Projects must be centered on evidence-based laboratory, data, and/or medical science.


Eligibility: MD, PhD or equivalent is required.


Must be 3 to 8 years from the start of an independent faculty research appointment as of 12/31/2025 (i.e., the official start date of the appointment must fall within the calendar years 2017-2022). 

Read More

Challenge Award for Metastatic Lethal Prostate Cancer

Due: May 5, 2025, 3 pm ET

Amount: Up to $1,000,000 per team/2 years

The grant support large-scale research projects concerning metastatic, lethal prostate cancer. Clinical trial costs are not allowed; however, correlative research to support high impact clinical trials for advanced prostate cancer is encouraged. All studies involving patients must include diverse participant populations with appropriate representation of ethnic and racial minority groups. Comprehensive statistical plans and power calculations are required. The following topics are solicited: theranostics; drugging currently undruggable oncology targets; first-in-field immunotherapies for prostate cancer; AI/machine learning to better inform patient

outcomes, host microbiome and tumor metabolism. Eligibility: Investigators representing non-profit academic research centers are eligible to apply. Teams should be at least 3 investigators to provide unique scientific expertise to metastatic, lethal prostate cancer. At least one young investigator (within 6 years of degree and no more than $2M in funding) must be on the team.

Applicants with VA appointments highly encouraged to apply.

Link: PCF RFP

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

National Multiple Sclerosis Society: Career Transition Fellowships

Due: May 14, 2025 (pre-application)

Amount: $600,000 over 5 years

To foster the development and productivity of young scientists who have potential to make significant contributions to MS research and help ensure the future and stability of MS research. The award provides approximately $600,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment. Applicants must have more than two years of postdoctoral research experience and no more than five years of postdoctoral research experience at the time of application.

Link: Career Transition Fellowships | National MS Society

Read More

Reproductive Scientist Development Program

Due: May 15, 2025 (LOI)

Amount: $250,000 over 2 years is salary support

Proposed research “must be translational in nature and relate to the field of maternal fetal health – with a focus on prematurity, maternal and infant morbidity and mortality and health equity.” PI Must be seeking a career in academic obstetrics and gynecology research. Applicants must be near completion of their residency in obstetrics and gynecology or in their subspecialty fellowship. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Prior laboratory experience is not required.

Link: Reproductive Scientist Development Program | March of Dimes

Read More

Cystic Fibrosis Foundation RFAs For Researchers

Researchers, supported by the Cystic Fibrosis Foundation, have made tremendous advances to improve the health and quality of life of people with CF. The CF Foundation is dedicated to providing the tools and resources that researchers need to continuously expand on this work. The following RFAs are now accepting applications with a full application deadline of May 15, 2025:




Read More

TACTICAL Award - Targeting Mechanisms of Lethal Prostate Cancer

LOI Due: May 19, 2025

Amount: $5M - $10M/3 to 5 years


The award is for teams of academic scientists’ high-risk, currently unfunded projects in metastatic, lethal prostate cancer. Clinical trial costs are not allowed; however, correlative research to support high impact clinical trials for advanced prostate cancer is encouraged.

Research proposals in the following topic areas are solicited: Theranostics, Drugging currently undruggable oncology targets: preventing progression to lethal disease, Improved biotechnologies for precision medicine, First-in-field immunotherapies for prostate cancer, Artificial intelligence/machine learning to better inform patient outcomes, and Host microbiome and tumor metabolism.Teams must be composed of at 5 investigators, including 2 young investigators. Teams with a young investigator as part of senior leadership will be favored. Team members must represent a minimum of four (4) non-profit academic research institutions.


Eligibility: Young investigators may be Postdoctoral Fellow, Instructor, Research

Associate, Assistant Professor, or equivalent and must be within six- years following

completion of a professional degree (MD, DO, PhD, MD-PhD, DSc, ScD, DDM, DDS, DMD, MBBS, or equivalent) or subsequent mentored academic or clinical training program, such as a postdoctoral or clinical fellowship. They should each not have been granted commitments for more than $2,000,000 in direct research funding from all sources including institutional funds at the time of this application.

Link: View and Download RFA

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

Systems 4 Action: Community-Led Systems Research to Address Systemic Racism

Due: June 4, 2025, @ 3pm

Amount: $200,000/1 year

To pave a future where health is no longer a privilege, but a right, RWJF is focusing on dismantling structural racism, one of the biggest barriers to health in America. Effective solutions require medical care organizations working with public health and social services systems. This grant will provide funding for a new cohort of community-led pilot studies to produce new, actionable evidence about how to help medical, social, and public health systems work together to address forms of systemic racism. The focus is specifically on systems alignment (SA) interventions that have the potential to dismantle or disrupt the health effects of systemic racism and to positively affect the health and wellbeing of communities that experience systemic racism. S4A prioritizes SA interventions that, if successful, can be rapidly replicated and spread to many communities and contexts across the U.S. in order to achieve broad national impact.

Link: Systems 4 Action RFP

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

Harrington Scholar-Innovator Award| Harrington Discovery Institute at University Hospitals

Due: June 4, 2025

Amount: $100,000/2 years

Opportunity to compete for acceleration funds up to $300,000. The Scholar Award

recognizes outstanding physician-scientists whose work has the potential to advance the standard of care. The selection committee seeks breakthrough discoveries defined by innovation, creativity and potential for clinical impact, including deemed to address unmet medical needs; modulators of novel targets; potential to be developed into a commercial program; strong intellectual property (IP) or protection strategy; may be a small molecule, biologic, or other therapeutic modality; or diagnostics or devices only acceptable as part of a therapeutic development project.

Eligibility: MD, MD/PhD, or equivalent.

Link: Scholar-Innovator Award

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

Damon Runyon-Rachleff Innovation Award

Due: July 1, 2025, 4pm

Amount: $400,000/2 years

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. Applications will be accepted from all scientific disciplines provided that the proposed research meets the selection criteria.


Eligibility: The applicant must have received an MD, DO, PhD, or MD/PhD degree. Tenure-track Assistant Professors within the first five (5) years of obtaining their initial Assistant Professor position (Cut-off date: July 1, 2020). Clinical Instructors

and Senior Clinical Fellows (in the final year of sub-specialty training) holding an MD, MD/PhD, DO who are pursuing a period of independent research before taking a tenure-track faculty position. Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and the support of their institution. Applicants with a background in multiple disciplines are especially encouraged to apply.


Link: Damon Runyon-Rachleff Innovation Award

Please contact the Institutional Giving team at institutionalgiving@montefiore.org for further details.

Read More

2025 Discovery and Innovation Award - WNY BloodCare

This program has been established to promote, nurture and amplify scientific discovery and innovation in Western New York and the region. The WNYBC Discovery and Innovation Award will support basic, translational, and/or clinical research projects that will improve health outcomes, health equity, and/or preventing complications of hemophilia and/or hemostatic or thrombotic disorders.

 

We invite proposals from higher education institutions and non-profit organizations that have a history and track record of serving the community of bleeding and clotting disorders. There is no age requirement, however, applicant must have an MD, PhD or equivalent; clearly state they have both independent research projects and independent resources; and have preliminary results/and or publications from their independent laboratory.

 

Budget must not exceed $150,000/year, for up to three years. Up to two grants will be awarded annually.

 

APPLICATION DUE DATE July 1, 2025

GRANT START DATE  January 1, 2026

 

Attached please find the 2025 Grant RFP

 

QUESTIONS? Check the attached FAQs first.  

 

More Questions?

Contact the Grant and Award Administrator at mwiseman@wnybloodcare.org

Read More

Limited submissions

2025 Google PhD fellowship program

The Albert Einstein College of Medicine has been invited to submit four student applications for consideration for the Google PhD Fellowship Program 2025. The Google PhD Fellowship Program was created to recognize outstanding graduate students doing exceptional and innovative research in areas relevant to computer science and related fields. Fellowships support promising PhD candidates of all backgrounds who seek to influence the future of technology.

 

The Google PhD Fellowship includes:

  • Up to 2-year Fellowship
  • $85K per year: $70K Cost of Education allowance towards tuition and fees and $15K stipend to be used for living expenses, travel and personal equipment (effective from 2025 for new recipients)
  • A Google Research Mentor

To implement the application process for this competition, eligible students are invited to submit preliminary applications for review. We will then select up to four candidates, who will be invited to submit the full proposal to Google.


The deadline for submission of preliminary applications is Friday, May 2nd. Please complete the attached pre-application form and send with your updated CV as a single email to: jomaris.sciarrone@einsteinmed.edu. Please put Google in the subject line for this email.

 

For further details of the program, application process, and eligibility requirements, please visit this FAQ page on the Google PhD Fellowship website.

Read More

Medical Research and Science & Engineering Grants - W.M. Keck Foundation

The W.M. Keck Foundation is offering research grants up to $1.3M over three years. The first step is for Einstein to submit to the foundation up to four concept papers each in Medical Research and Science & Engineering.

 

If you are interested in applying, please email your c.v., including bibliography; other support(on a separate page); plus a one-page concept paper following the *outline below to Audrey McInerney (amcinerney@montefiore.org) by May 30 at 5:00 pm.

 

Please indicate whether your concept paper will compete in the Medical Research or Science & Engineering pool.

 

From among the internal concept papers, the Einstein awards committee will select up to four candidates in each of the two categories, for a total of up to eight concept candidates. Einstein’s institutional liaison will then submit the nominated concept papers to the Foundation for a preliminary review on June 23, 2025. Following this review, one selected applicant in each category will be invited to submit a Phase I application by November 1, 2025.



The Keck Foundation funds high-risk/high-impact projects that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. They prioritize grants that pioneer biological and physical science research and engineering, including the development of promising new technologies, instrumentation, or methodologies. Future clinical applications are seen as a plus, but translational research is not their focus. Please note: The Keck Foundation defines medical research as “a focus on the human body and mammalian experimentation” and they seek a basic science impact in both medical research and science & engineering applications.


Eligibility: Senior, mid-career, and early-stage faculty (assistant professors and above) can apply.  If you are unsure about your eligibility, please contact your department administrator or Audrey McInerney (amcinerney@montefiore.org) for assistance.

 

Important: Please review the Keck Foundation’s Funding Guidelines to see what kinds of projects the foundation will and will not fund (scroll down).

  

*Outline for one-page concept paper submissions to Einstein Awards Committee

12-point font with 1-inch margins and MUST include: 

  • Organization Name 
  • Project Title 
  • Full name of Principal Investigator 
  • An overview of the proposed project emphasizing any unique aspects and pilot studies (indicate area of emphasis for project – Medical Research or Science & Engineering Research) 
  • A description of the methodologies and key personnel 
  • A brief justification of the need for Keck Foundation support. (Applicants need to demonstrate why private philanthropy generally, and the Keck Foundation in particular, is essential to the project’s success. The foundation advises applicants to insert quotes received from public funding agencies feedback as to why their project did not get funded, e.g., “high-quality but too risky”). 
  • An estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies, etc. 
  • With any remaining space within the 1-page limit, authors may add other details 
  • If a reference is necessary, abbreviate it as (Science, 323, 45, ‘11). DO NOT USE (Jones et al., 2011). Please avoid any illustrations.   

 

Please find additional information about the Keck Foundation’s Research Program here. And visit the Foundation's Grant Abstracts Webpage to view recently funded research projects and award amounts. Please note: If your project is similar to a recent award, the Keck board will not be interested.

 

If you have any questions, please contact amcinerney@montefiore.org (Institutional Liaison).

Read More

2025 SINSHEIMER SCHOLAR AWARD


Albert Einstein College of Medicine has been invited to submit one Assistant Professor for consideration for the 2025 Sinsheimer Scholar Award  from the Alexandrine and Alexander L. Sinsheimer Fund. The fund provides “funding to individuals who demonstrate potential for making major contributions with respect to the prevention or cure of human disease.” The Sinsheimer Scholar Award carries an annual grant of $100,000 per year for two years.


Eligibility of the applicant:


Shall not be in more than the fifth year of their Assistant Professorship as of the Spring Semester 2025. 


This competition is applicable even to those who have not yet received prestigious awards for their research. 


If you have already received substantial independent funding, you will not qualify for this grant. As per the Fund, if the $200,000 is not needed for the researcher to accomplish their goals, then the funding is unlikely to be awarded.


In order to implement the application process for this competition, eligible faculty members are invited to submit preliminary applications, upon the recommendation of the appropriate department chair(s), for review by Einstein's Awards Committee. From among these applications, the Committee will select one candidate who will be invited to submit their full proposal to the Fund by July 1st, 2025. 

 

The deadline for submission of preliminary applications is 5 PM, Friday, June 6th, 2024. 


Please submit the following as an email attachment to applicationsubmission@einsteinmed.edu.


single (ONE) electronic, PDF file containing the following:

 

a.  Completed Candidate Profile Form. [Click here]


b.  A research plan (limited to five pages) to include:

i) Objectives or aims of research, including significance of research and/or broader impact to the field

ii) Design/methods

iii) Expected results

iv) How would you use these funds in a way that would be most transformative for your research?

v) Is there an overlap with this award in another lab?

The font should be 11-point or larger, and the margins should be at least 0.5 inches. Figure legends can use smaller fonts.


c.  A complete curriculum vitae and bibliography. Do NOT submit an NIH biosketch.  


d.  Budget for project, with justification (1 page)

     i) Please note that indirect costs are not allowed as part of the project budget.

     ii) Please denote any matching funds from other sources, including your academic institution. Note that indirect costs covered by the academic institution are NOT considered matching funds.

 

e.  Information about current and pending grant support with amounts requested or approved, annual amounts, and duration of award (1 page).

 

f.   Letter of recommendation from sponsoring department Chairperson, approved by the Dean of Medical School.

 

To know in advance about the requirements for the final application to the Sinsheimer Fund, please find the attached PDF with detailed instructions for the final submission. Please note that for our internal review, you should follow the directions detailed above, not the attached guidelines for the final application.


Link: Guidelines for the final application

Please note the OGS email address: OGS@einsteinmed.edu